#VisualAbstract: Atezolizumab added to cabozantinib does not improve clinical outcomes in patients with metastatic renal cell carcinoma

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.